The vitamin D receptor gene bAt (CCA) haplotype impairs the response to pegylated-interferon/ribavirin-based therapy in chronic hepatitis C patients
Published inAntiviral therapy, vol. 17, no. 3, p. 541-547
Publication date2012
Abstract
Keywords
- Adult
- Aged
- Antiviral Agents/therapeutic use
- Cohort Studies
- Drug Therapy, Combination
- Female
- Genotype
- Haplotypes/genetics
- Hepacivirus/drug effects/genetics
- Hepatitis C, Chronic/drug therapy/genetics/virology
- Humans
- Interferons/therapeutic use
- Male
- Middle Aged
- Polyethylene Glycols/therapeutic use
- Polymorphism, Genetic
- Receptors, Calcitriol/genetics
- Ribavirin/therapeutic use
- Treatment Outcome
- Vitamin D/blood
Citation (ISO format)
BAUR, Katharina et al. The vitamin D receptor gene bAt (CCA) haplotype impairs the response to pegylated-interferon/ribavirin-based therapy in chronic hepatitis C patients. In: Antiviral therapy, 2012, vol. 17, n° 3, p. 541–547. doi: 10.3851/IMP2018
Main files (1)
Article (Published version)

Identifiers
- PID : unige:27573
- DOI : 10.3851/IMP2018
- PMID : 22300961
ISSN of the journal1359-6535